{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:45:31Z","timestamp":1778651131039,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s13555-023-00985-1","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T08:03:23Z","timestamp":1689926603000},"page":"2121-2126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6430-268X","authenticated-orcid":false,"given":"Alessia","family":"Villani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Micali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Potestio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Scalvenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"issue":"8","key":"985_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/14740338.2021.1921734","volume":"20","author":"A Villani","year":"2021","unstructured":"Villani A, Fabbrocini G, Costa C, et al. Expert opinion on sonidegib efficacy, safety and tolerability. Expert Opin Drug Saf. 2021;20(8):877\u201382.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"985_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4081\/oncol.2020.420","volume":"14","author":"A Furdova","year":"2020","unstructured":"Furdova A, Kapitanova K, Kollarova A, et al. Periocular basal cell carcinoma - clinical perspectives. Oncol Rev. 2020;14(1):420.","journal-title":"Oncol Rev"},{"issue":"5","key":"985_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/IOP.0000000000002173","volume":"38","author":"F Hassanin","year":"2022","unstructured":"Hassanin F, Al Hussain H, Maktabi A, et al. Periocular pigmented basal cell carcinomas: clinicopathologic features and mutational profile. Ophthalmic Plast Reconstr Surg. 2022;38(5):475\u201382.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"985_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejca.2019.06.003","volume":"118","author":"K Peris","year":"2019","unstructured":"Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer. 2019;118:10\u201334.","journal-title":"Eur J Cancer"},{"issue":"3","key":"985_CR5","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s12325-022-02044-1","volume":"39","author":"A Villani","year":"2022","unstructured":"Villani A, Potestio L, Fabbrocini G, et al. New emerging treatment options for advanced basal cell carcinoma and squamous cell carcinoma. Adv Ther. 2022;39(3):1164\u201378.","journal-title":"Adv Ther"},{"issue":"9","key":"985_CR6","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1111\/jdv.16230","volume":"34","author":"R Dummer","year":"2020","unstructured":"Dummer R, Ascierto PA, Basset-Seguin N, et al. Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion. J Eur Acad Dermatol Venereol. 2020;34(9):1944\u201356.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"985_CR7","doi-asserted-by":"publisher","first-page":"758","DOI":"10.4103\/ijdvl.IJDVL_92_18","volume":"84","author":"M Scalvenzi","year":"2018","unstructured":"Scalvenzi M, Villani A, Mazzella C, et al. Vismodegib treatment in a HIV positive patient on antiretroviral therapy. Indian J Dermatol Venereol Leprol. 2018;84(6):758\u201360. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_92_18.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"10","key":"985_CR8","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3390\/cancers14102496","volume":"14","author":"LE Grossmann","year":"2022","unstructured":"Grossmann LE, Ramelyte E, N\u00e4geli MC, et al. Eight years of real-life experience with smoothened inhibitors in a Swiss tertiary skin referral center. Cancers (Basel). 2022;14(10):2496.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"985_CR9","first-page":"9240","volume":"13","author":"V De Giorgi","year":"2021","unstructured":"De Giorgi V, Trane L, Pieretti G, et al. Treatment of periocular advanced basal cell carcinoma with Hedgehog pathway inhibitors: a single-center study and a new dedicated therapeutic protocol. Dermatol Reports. 2021;13(3):9240.","journal-title":"Dermatol Reports"},{"issue":"10","key":"985_CR10","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s00417-020-04779-5","volume":"258","author":"X Hou","year":"2020","unstructured":"Hou X, Rokohl AC, Ortmann M, et al. Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor? Graefes Arch Clin Exp Ophthalmol. 2020;258(10):2335\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"985_CR11","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1007\/s00417-021-05311-z","volume":"259","author":"AC Rokohl","year":"2021","unstructured":"Rokohl AC, Heindl LM. Effective systemic treatment of advanced periocular basal cell carcinoma with sonidegib. Graefes Arch Clin Exp Ophthalmol. 2021;259(12):3821\u20132.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"985_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3889\/oamjms.2018.012","volume":"6","author":"G Tchernev","year":"2018","unstructured":"Tchernev G, Lotti T, Lozev I, et al. Locally advanced basal cell carcinoma with intraocular invasion. Open Access Maced J Med Sci. 2018;6(1):126\u20137.","journal-title":"Open Access Maced J Med Sci"},{"issue":"1","key":"985_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","volume":"112","author":"A Freites-Martinez","year":"2021","unstructured":"Freites-Martinez A, Santana N, Arias-Santiago S, et al. Using the common terminology criteria for adverse events (CTCAE - Version 5.0) to evaluate the severity of adverse events of anticancer therapies. CTCAE versi\u00f3n 5.0. Evaluaci\u00f3n de la gravedad de los eventos adversos dermatol\u00f3gicos de las terapias antineopl\u00e1sicas. Actas Dermosifiliogr (Engl Ed). 2021;112(1):90\u20132.","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"issue":"6","key":"985_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S1470-2045(15)70100-2","volume":"16","author":"MR Migden","year":"2015","unstructured":"Migden MR, Guminski A, Gutzmer R, et al. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol. 2015;16(6):716\u201328.","journal-title":"Lancet Oncol"},{"issue":"1","key":"985_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/14740338.2022.1993819","volume":"21","author":"A Villani","year":"2022","unstructured":"Villani A, Ocampo-Garza SS, Potestio L, et al. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma. Expert Opin Drug Saf. 2022;21(1):21\u20139.","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"985_CR16","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.3390\/ijms23126388","volume":"23","author":"A Villani","year":"2022","unstructured":"Villani A, Potestio L, Fabbrocini G, et al. The treatment of advanced melanoma: therapeutic update. Int J Mol Sci. 2022;23(12):6388.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"985_CR17","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1111\/jocd.14938","volume":"21","author":"M Megna","year":"2022","unstructured":"Megna M, Camela E, Villani A, et al. Teledermatology: a useful tool also after COVID-19 era? J Cosmet Dermatol. 2022;21(6):2309\u201310.","journal-title":"J Cosmet Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00985-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-00985-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00985-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T19:06:17Z","timestamp":1692644777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-00985-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["985"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-00985-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}